US Patent 9896516 Animal models and therapeutic molecules
Patent 9896516 was granted and assigned to Kymab on February, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9896516 Animal models and therapeutic molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
